# Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics

> **NCT03535402** · PHASE3 · UNKNOWN · sponsor: **Gaylis, Norman B., M.D.** · enrollment: 20 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Sarilumab

## Key facts

- **NCT ID:** NCT03535402
- **Lead sponsor:** Gaylis, Norman B., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03535402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03535402, "Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03535402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*